WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013

Dec 2, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-27

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-27	Common Stock	S	5000.0000	$49.2639	Disposed	965801.3732	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2683.4400	Indirect
Common Stock	41713.5742	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold on the same date in multiple transactions at prices ranging from $49.23 to $49.30, inclusive. The reporting person undertakes to provider to issuer, any security holder of issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.